Heal Capital

What is Heal Capital?

Heal Capital is a venture capital firm based in Germany with a specialized focus on the healthtech sector.

Their investment strategy lies at the intersection of healthcare and technology, targeting companies that provide innovative solutions across the full patient journey. With a commitment to redefining healthcare through technology, they support mission-driven founders who aim to make significant impacts in their fields.

Heal Capital offers capital and immediate access to the healthcare system for startups, enabling them to scale and reach their potential. Their investments range from 1 to 5 million euros, preferring to engage in Pre-Seed to Series A rounds.

The fund's specialty lies in seed and early-stage investments, with an investment 'sweet spot' of around 3 million euros, which demonstrates their commitment to nurturing startups during the crucial early phases of growth.

They focus on a wide array of industries within the healthtech domain, including but not limited to BioTech, A.I. and Big Data, HealthTech and Fitness, Impact, Medical Devices and Hospital Services, Healthcare and Wellness, Consumer, and Pharmaceutical and Medicine domains. Additionally, they have an interest in ventures that emphasize women's health and wellness.

This diversified yet targeted investment approach reflects a clear dedication to fostering innovation and improvement in healthcare services and solutions, ultimately aiming to contribute to a more effective, efficient, and accessible healthcare ecosystem. As evidenced by their portfolio and team structure, Heal Capital offers more than just capital; they extend a valuable network and knowledge base specifically tailored to support healthtech entrepreneurs in Europe.

What they say:

Heal Capital is a healthtech specialist fund that invests at the convergence of healthcare and technology across the full patient journey